title: Transcatheter intervention following bosentan-iloprost treatment in a patient with patent ductus arteriosus and pulmonary hypertension.
authors.forename: Alper
authors.initials: A
authors.lastname: Guzeltas
authors.forename: Ender
authors.initials: E
authors.lastname: Odemis
authors.forename: Meki
authors.initials: M
authors.lastname: Bilici
authors.forename: I Cansaran
authors.initials: IC
authors.lastname: Tanidir
authors.forename: İsa
authors.initials: İ
authors.lastname: Özyılmaz
mesh_terms: D000328:Adult; D000959:Antihypertensive Agents / Q000008:administration & dosage; D000077300:Bosentan; D004374:Ductus Arteriosus, Patent / Q000150:complications / Q000601:surgery*; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000209:etiology; D016285:Iloprost / Q000008:administration & dosage*; D055989:Septal Occluder Device; D013449:Sulfonamides / Q000008:administration & dosage*; D014665:Vasodilator Agents / Q000008:administration & dosage
chemical_list: D000959:Antihypertensive Agents; D013449:Sulfonamides; D014665:Vasodilator Agents; D016285:Iloprost; D000077300:Bosentan